Total Assets$XTALPI(02228.HK)On March 19-20, 2026, the PMO 2026 3rd Metabolism & Weight Loss and Peptide Drugs Summit will focus on the frontiers of metabolic disease and peptide drug R&D, bringing together experts, industry representatives, and technology pioneers from the global biopharmaceutical field to jointly explore innovative breakthroughs and clinical translation practices of peptide drugs in areas such as metabolism and weight loss.
On March 19, Dr. Zhang Genwei, Head of the Peptide and Protein Technology Department of XtalPi, is invited by the conference to deliver a keynote speech titled "AI-Driven Next-Generation Cyclic Peptide Drug Discovery" from 11:30-12:00 at [Forum 1: PMO Metabolism & Peptide Drugs] (Forum Venue: Shanghai St. Regis Crown Plaza Hotel, 3rd Floor, Asia-America Hall 2). Based on the cutting edge of AI drug development technology, he will engage in in-depth discussions with industry peers on innovative pathways and core values in peptide drug R&D.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
